clonidine has been researched along with Bernard Syndrome in 48 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 40-year-old man developed a Horner syndrome as part of a dorsolateral medullary brainstem infarction." | 6.46 | Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke. ( Debroucker, T; Lebas, M; Seror, J, 2010) |
| "Apraclonidine (0." | 5.33 | The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. ( Acaroglu, G; Firat, E; Kansu, T; Kavuncu, S; Koc, F, 2005) |
| " Two children with anisocoria, one of whom had Horner Syndrome confirmed with apraclonidine 1% and the other, in whom an apraclonidine test ruled out this syndrome but in whom pilocarpine 0." | 3.75 | [Usefulness of apraclonidine in the diagnosis of Horner syndrome]. ( Alias, E; Díaz, S; Fernández, FJ; Ferrer, C; González, I; Honrubia, FM; Pérez-Iñigo, MA, 2009) |
| "To determine the location of action of apraclonidine, an alpha-adrenergic receptor agonist that reduces aqueous production and lowers intraocular pressure (IOP)." | 3.70 | Ocular effects of apraclonidine in Horner syndrome. ( Abdul-Rahim, AS; Brown, SM; Crosson, CE; Morales, J, 2000) |
| "The diagnosis of Horner's syndrome (HS) can be difficult, as patients rarely present with the classic triad of ptosis, miosis, and anhydrosis." | 2.49 | Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm. ( Daniel, CS; Davagnanam, I; Fraser, CL; Miszkiel, K; Plant, GT, 2013) |
| "Apraclonidine seems to be a good alternative to cocaine to confirm Horner's syndrome." | 2.47 | [Acquired Horner's syndrome]. ( Alstadhaug, KB, 2011) |
| "A 40-year-old man developed a Horner syndrome as part of a dorsolateral medullary brainstem infarction." | 2.46 | Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke. ( Debroucker, T; Lebas, M; Seror, J, 2010) |
| "First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculosympathetic pathway." | 2.45 | Current pharmacologic testing for Horner syndrome. ( Longmuir, R; Mughal, M, 2009) |
| "Apraclonidine 0." | 1.72 | The evaluation of patient demographics, etiologies and apraclonidine test results in adult Horner's syndrome. ( Celebisoy, N; Gokcay, F; Karti, O; Saruhan Durmaz, G; Top Karti, D, 2022) |
| "The utility of apraclonidine in acute Horner syndrome remains controversial as the exact timing for denervation sensitivity to develop remains unknown." | 1.56 | Apraclonidine for the pharmacologic confirmation of acute Horner syndrome. ( Farahvash, A; Micieli, JA; Nguyen, MTB; Zhang, A, 2020) |
| "Apraclonidine hydrochloride is a topical ophthalmic solution with selective alpha-2 and weak alpha-1 receptor agonist activity that has the ability to elevate the eye lid." | 1.46 | Apraclonidine in the treatment of ptosis. ( Jankovic, J; Vijayakumar, D; Wijemanne, S, 2017) |
| "Nineteen patients with unilateral Horner syndrome (Horner group) and age-matched controls of 30 healthy individuals with normal vision and neither optic nerve dysfunction nor pupillary abnormalities were included." | 1.46 | Efficacy of digital pupillometry for diagnosis of Horner syndrome. ( Hwang, JM; Yang, HK; Yoo, YJ, 2017) |
| "The diagnosis of Horner syndrome (HS) using apraclonidine eye drops is an alternative to the use of topical cocaine drops." | 1.37 | Early diagnosis of Horner syndrome using topical apraclonidine. ( Cooper-Knock, J; Hodgson, T; Pepper, I; Sharrack, B, 2011) |
| "Apraclonidine 0." | 1.35 | Topical apraclonidine to diagnose Bernard-Horner syndrome. ( Gocmez, E; Kocabora, M; Taskapili, M, 2009) |
| "(3,4) We report adverse effects of topical apraclonidine when used in the diagnosis of Horner syndrome in infants." | 1.34 | Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. ( Lim, MK; Satterfield, D; Watts, P, 2007) |
| "Apraclonidine (0." | 1.33 | The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. ( Acaroglu, G; Firat, E; Kansu, T; Kavuncu, S; Koc, F, 2005) |
| "A diagnosis of Horner's syndrome (HS) was presumed and was confirmed by instillation of apraclonidine eye drops." | 1.33 | Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis. ( Baser, EF; Mirzai, H, 2006) |
| "Three patients with Horner syndrome showed positive values (reversal of anisocoria) only under high ambient illumination, but not under low illumination." | 1.33 | Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. ( Chen, JT; Chen, PL; Chen, WY; Hsiao, CH; Lu, DW, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.08) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (43.75) | 29.6817 |
| 2010's | 20 (41.67) | 24.3611 |
| 2020's | 6 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Top Karti, D | 1 |
| Karti, O | 1 |
| Saruhan Durmaz, G | 1 |
| Gokcay, F | 1 |
| Celebisoy, N | 1 |
| Eldib, AA | 1 |
| Patil, P | 1 |
| Nischal, KK | 1 |
| Mitchell, ER | 1 |
| Hiasat, JG | 1 |
| Pihlblad, MS | 1 |
| Bellégo, C | 1 |
| Borruat, FX | 2 |
| Kawasaki, A | 2 |
| Kraker, JA | 1 |
| Tajfirouz, DA | 1 |
| Bhatti, MT | 1 |
| Chen, JJ | 1 |
| Margolin, E | 1 |
| Jeeva-Patel, T | 1 |
| Hainc, N | 1 |
| Nguyen, MTB | 1 |
| Farahvash, A | 1 |
| Zhang, A | 1 |
| Micieli, JA | 1 |
| Wijemanne, S | 1 |
| Vijayakumar, D | 1 |
| Jankovic, J | 1 |
| Yoo, YJ | 1 |
| Yang, HK | 1 |
| Hwang, JM | 1 |
| Sahin, CB | 1 |
| Chaudhary, N | 1 |
| Trobe, JD | 1 |
| Escrivá, E | 1 |
| Martínez-Costa, L | 1 |
| Kauh, CY | 1 |
| Bursztyn, LL | 1 |
| Chen, Y | 1 |
| Morgan, ML | 1 |
| Barros Palau, AE | 1 |
| Yalamanchili, S | 1 |
| Lee, AG | 1 |
| McInnis, CP | 1 |
| Haynor, DR | 1 |
| Francis, CE | 1 |
| Malem, A | 1 |
| Bohnsack, BL | 1 |
| Parker, JW | 1 |
| Pishdad, GR | 2 |
| Pishdad, P | 2 |
| Pishdad, R | 2 |
| Dewan, MA | 1 |
| Harrison, AR | 1 |
| Lee, MS | 1 |
| Pérez-Iñigo, MA | 1 |
| González, I | 1 |
| Fernández, FJ | 1 |
| Díaz, S | 1 |
| Ferrer, C | 1 |
| Alias, E | 1 |
| Honrubia, FM | 1 |
| Martín-Moro, JG | 1 |
| Botín, DM | 1 |
| Muñoz-Negrete, FJ | 1 |
| Mughal, M | 1 |
| Longmuir, R | 1 |
| Kocabora, M | 1 |
| Gocmez, E | 1 |
| Taskapili, M | 1 |
| Lebas, M | 1 |
| Seror, J | 1 |
| Debroucker, T | 1 |
| Sueke, H | 1 |
| Chandna, A | 1 |
| O'Connor, J | 1 |
| Rochford, M | 1 |
| O'Connor, G | 1 |
| Fanning, N | 1 |
| Chu, CJ | 1 |
| Ferris, JD | 1 |
| Pradhan, S | 1 |
| Goyal, G | 1 |
| Cooper-Knock, J | 1 |
| Pepper, I | 1 |
| Hodgson, T | 1 |
| Sharrack, B | 1 |
| Shin, RK | 1 |
| Cheek, AG | 1 |
| Alstadhaug, KB | 1 |
| Ramos, R | 1 |
| Ureña, A | 1 |
| Rivas, F | 1 |
| Macia, I | 1 |
| Rosado, G | 1 |
| Pequeño, S | 1 |
| Masuet, C | 1 |
| Badia, M | 1 |
| Miguel, M | 1 |
| Delgado, MA | 1 |
| Escobar, I | 1 |
| Moya, J | 1 |
| Yokoyama, T | 1 |
| Toga, A | 1 |
| Hashida, Y | 1 |
| Wakabayashi, Y | 1 |
| Hayashi, K | 1 |
| Kato, E | 1 |
| Davagnanam, I | 1 |
| Fraser, CL | 1 |
| Miszkiel, K | 1 |
| Daniel, CS | 1 |
| Plant, GT | 1 |
| Brown, SM | 4 |
| Aouchiche, R | 1 |
| Freedman, KA | 2 |
| Bacal, DA | 1 |
| Levy, SR | 1 |
| Kardon, R | 1 |
| Koc, F | 1 |
| Kavuncu, S | 1 |
| Kansu, T | 1 |
| Acaroglu, G | 1 |
| Firat, E | 1 |
| Chen, PL | 2 |
| Chen, JT | 2 |
| Lu, DW | 2 |
| Chen, YC | 1 |
| Hsiao, CH | 2 |
| Mirzai, H | 1 |
| Baser, EF | 1 |
| Chen, WY | 1 |
| Watts, P | 1 |
| Satterfield, D | 1 |
| Lim, MK | 1 |
| Chu, EA | 1 |
| Byrne, PJ | 1 |
| Moodley, AA | 1 |
| Spooner, RB | 1 |
| Morales, J | 1 |
| Abdul-Rahim, AS | 1 |
| Crosson, CE | 1 |
| Gmünder, HP | 1 |
| Girke, W | 1 |
4 reviews available for clonidine and Bernard Syndrome
| Article | Year |
|---|---|
Current pharmacologic testing for Horner syndrome.
Topics: Clonidine; Cocaine; False Negative Reactions; Horner Syndrome; Humans; p-Hydroxyamphetamine; Sympath | 2009 |
Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Horner Syndrome; Humans; Magnetic Resonance Angiography | 2010 |
[Acquired Horner's syndrome].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Clonidine; Cocaine; Diagnosis, Differential; Fema | 2011 |
Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm.
Topics: Adult; Algorithms; Angiography, Digital Subtraction; Clonidine; Cocaine; Diagnostic Imaging; Horner | 2013 |
1 trial available for clonidine and Bernard Syndrome
| Article | Year |
|---|---|
Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.
Topics: Adolescent; Child; Child, Preschool; Clonidine; Cocaine; Cross-Over Studies; Female; Horner Syndrome | 2006 |
43 other studies available for clonidine and Bernard Syndrome
| Article | Year |
|---|---|
The evaluation of patient demographics, etiologies and apraclonidine test results in adult Horner's syndrome.
Topics: Adult; Clonidine; Demography; Female; Horner Syndrome; Humans; Male; Middle Aged; Retrospective Stud | 2022 |
Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.
Topics: Adult; Child; Child, Preschool; Clonidine; Horner Syndrome; Humans; Infant; Ophthalmic Solutions; Op | 2021 |
Long-term prognosis of patients with idiopathic Horner syndrome.
Topics: Clonidine; Horner Syndrome; Humans; Prognosis; Pupil | 2022 |
Tachyphylaxis With Sustained Apraclonidine Use in the Treatment of Ptosis Associated With Horner Syndrome.
Topics: Blepharoptosis; Clonidine; Horner Syndrome; Humans; Tachyphylaxis | 2023 |
Horner's syndrome and apraclonidine eye drops.
Topics: Adrenergic alpha-2 Receptor Agonists; Cervical Vertebrae; Clonidine; Female; Horner Syndrome; Humans | 2020 |
Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
Topics: Adrenergic alpha-Agonists; Clonidine; Horner Syndrome; Humans; Motivation | 2020 |
Apraclonidine in the treatment of ptosis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Blepharoptosis; Botulinum Toxins; Clo | 2017 |
Efficacy of digital pupillometry for diagnosis of Horner syndrome.
Topics: Case-Control Studies; Clonidine; Female; Horner Syndrome; Humans; Light; Male; Pupil; Reflex, Pupill | 2017 |
Horner Syndrome as the Only Focal Neurologic Manifestation of Hypothalamic Hemorrhage.
Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Aged; Anisocoria; Clonidine; Femal | 2018 |
[Incomplete Horner's syndrome as a presenting sign of fourth ventricle ependymoma].
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Blepharoptosis; Cerebral Ventricle Neoplasms; Clonidine | 2013 |
Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage.
Topics: Aged; Clonidine; Diagnostic Techniques, Ophthalmological; Hemorrhage; Horner Syndrome; Humans; Magne | 2015 |
Evaluation and neuroimaging of the Horner syndrome.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Child; Child, Pres | 2015 |
Horner syndrome in fibromuscular dysplasia without carotid dissection.
Topics: Adrenergic alpha-2 Receptor Agonists; Blepharoptosis; Carotid Artery, Internal, Dissection; Clonidin | 2016 |
Unequal pupils and ptosis.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Anisocoria; Blepharoptosis; Carotid Arteries; Clonidine; | 2017 |
Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Carotid Artery, Internal; Ca | 2008 |
Pupillary autonomic neuropathy simulating partial Horner syndrome in diabetes mellitus and its reversal with control of blood glucose.
Topics: Adrenergic alpha-Agonists; Anisocoria; Blood Glucose; Clonidine; Diabetic Neuropathies; Female; Horn | 2008 |
False-negative apraclonidine testing in acute Horner syndrome.
Topics: Acute Disease; Adrenergic alpha-Agonists; Anisocoria; Carotid Artery, Internal, Dissection; Clonidin | 2009 |
[Usefulness of apraclonidine in the diagnosis of Horner syndrome].
Topics: Adrenergic alpha-Agonists; Adult; Anisocoria; Birth Injuries; Brachial Plexus; Clonidine; Cocaine; D | 2009 |
Possible effect of systemic sympathicolytic drugs on apraclonidine test.
Topics: Acute Disease; Adrenergic alpha-Agonists; Anisocoria; Carotid Artery, Internal, Dissection; Clonidin | 2009 |
Topical apraclonidine to diagnose Bernard-Horner syndrome.
Topics: Administration, Topical; Adult; Child; Clonidine; Female; Horner Syndrome; Humans; Male; Pupil | 2009 |
Using apraclonidine in diagnosing Horner syndrome in children.
Topics: Adrenergic alpha-Agonists; Clonidine; Dark Adaptation; Horner Syndrome; Humans; Light; Photography; | 2010 |
Pharmacological diagnosis of Horner's syndrome in the emergency department.
Topics: Adrenergic alpha-2 Receptor Agonists; Anticoagulants; Clonidine; Female; Horner Syndrome; Humans; Ma | 2011 |
Horner's syndrome as a complication of percutaneous ethanol treatment of thyroid nodule.
Topics: Clonidine; Ethanol; Female; Horner Syndrome; Humans; Middle Aged; Thyroid Nodule | 2011 |
Confirmation of Horner's syndrome using apraclonidine eye drops.
Topics: Adrenergic alpha-2 Receptor Agonists; Clonidine; Horner Syndrome; Humans; Male; Middle Aged; Ophthal | 2011 |
Teaching NeuroImages: honeycomb appearance of the brain in a patient with Canavan disease.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Clonidine; Female; Horner Syndrome; Humans | 2011 |
Early diagnosis of Horner syndrome using topical apraclonidine.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adult; Anisocoria; Carotid Artery, In | 2011 |
Teaching NeuroImages: Positive apraclonidine test in Horner syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Blepharoptosis; Clonidine; Diskectomy; Female; Horner Syndrome; Hu | 2011 |
Impact of T3 thoracoscopic sympathectomy on pupillary function: a cause of partial Horner's syndrome?
Topics: Adolescent; Adult; Clonidine; Equipment Design; Horner Syndrome; Humans; Hyperhidrosis; Intraoperati | 2012 |
Hemifacial flushing after bathing and crying.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Baths; Clonidine; Crying; Diagnosis, | 2012 |
The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anisocoria; Clonidine; Drug Evaluation; Female; Horner Syndr | 2003 |
The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Anisocoria; Child; Clonidine; Female; Horner Syndrome; Humans | 2004 |
The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
Topics: Adrenergic alpha-Agonists; Anisocoria; Clonidine; Horner Syndrome; Humans; Ophthalmic Solutions | 2005 |
Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?
Topics: Adrenergic alpha-Agonists; Clonidine; Cocaine; Dopamine Uptake Inhibitors; Horner Syndrome; Humans | 2005 |
Topical apraclonidine in the diagnosis of suspected Horner syndrome.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adult; Child, Preschool; Clonidine; Cocaine; Dop | 2005 |
The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
Topics: Adrenergic alpha-Agonists; Adult; Anisocoria; Blepharoptosis; Clonidine; Diabetic Neuropathies; Fema | 2005 |
Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis.
Topics: Adrenergic alpha-Agonists; Clonidine; Diagnosis, Differential; Female; Horner Syndrome; Humans; Infa | 2006 |
Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
Topics: Adolescent; Adrenergic alpha-Agonists; Child; Child, Preschool; Clonidine; Dark Adaptation; Female; | 2006 |
Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
Topics: Adrenergic alpha-Agonists; Bradycardia; Clonidine; Emergency Treatment; Female; Horner Syndrome; Hum | 2007 |
Pharmacologic reversal of Horner's syndrome-related ptosis with apraclonidine.
Topics: Adrenergic alpha-Agonists; Adult; Blepharoptosis; Clonidine; Female; Horner Syndrome; Humans; Treatm | 2007 |
Apraclonidine in the diagnosis of Horner's syndrome.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Aged; Clonidine; Horner Syndrome; Humans; Male | 2007 |
False negative apraclonidine test in two patients with Horner syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; False Negative Reactions; Female; Horner Syndrome; Huma | 2008 |
Ocular effects of apraclonidine in Horner syndrome.
Topics: Adrenergic alpha-Agonists; Aqueous Humor; Ciliary Body; Clonidine; Cohort Studies; Horner Syndrome; | 2000 |
[Clonidine in the diagnosis of Horner syndrome].
Topics: Adult; Aged; Blood Pressure; Clonidine; Diagnosis, Differential; Female; Heart Rate; Horner Syndrome | 1989 |